Columbia Partners Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-29,826
Closed -$2.25M 179
2018
Q1
$2.25M Buy
29,826
+26,049
+690% +$2.07M 0.29% 106
2017
Q4
$270K Buy
3,777
+791
+26% +$60.1K 0.04% 200
2017
Q3
$241K Buy
+2,986
New +$228K 0.03% 224
2016
Q2
Sell
-27,075
Closed -$2.49M 348
2016
Q1
$2.49M Buy
27,075
+6,350
+31% +$573K 0.18% 159
2015
Q4
$2.1M Sell
20,725
-6,349
-23% -$661K 0.15% 176
2015
Q3
$2.66M Sell
27,074
-10,003
-27% -$1.11M 0.19% 143
2015
Q2
$4.34M Sell
37,077
-229
-0.6% -$25K 0.27% 124
2015
Q1
$3.66M Sell
37,306
-95,050
-72% -$9.65M 0.19% 150
2014
Q4
$12.5M Sell
132,356
-2,199
-2% -$227K 0.65% 46
2014
Q3
$14.3M Sell
134,555
-37,497
-22% -$3.67M 0.73% 27
2014
Q2
$14.3M Sell
172,052
-30,347
-15% -$2.36M 0.66% 38
2014
Q1
$14.3M Buy
202,399
+84,520
+72% +$6.63M 0.63% 47
2013
Q4
$8.85M Buy
117,879
+694
+0.6% +$48.3K 0.38% 99
2013
Q3
$7.37M Buy
117,185
+689
+0.6% +$41.2K 0.33% 113
2013
Q2
$5.97M Buy
+116,496
New +$6.07M 0.28% 126

Other funds holding GILD

Columbia Partners Investment Management's GILD Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 29,826 shares — an estimated $2.25M sold.

Columbia Partners Investment Management first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $14.3M in Q1 2014. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Columbia Partners Investment Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 29,826 Gilead Sciences shares in Q2 2018, an estimated $2.25M.
  • Columbia Partners Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
  • Columbia Partners Investment Management's Gilead Sciences position peaked at $14.3M in Q1 2014.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.